$2.00
▼ -1.5% Today
as of Jul 22, 16:48 ET
Last 30 days
Recent Press Releases & News
Entera Bio Stock Rallies 35% in a Month: Here's What You Should Know
ENTX Stock On Track For Best Day In Over 5 Years — What’s Driving The Rally?
Entera Bio Advances Oral Osteoporosis Drug EB613 With Positive FDA Feedback
Overview
52-week range
$0.91
$3.22
47% of range
Avg surprise (last 2)
+13.4%
Avg reaction (last 2)
-4.1%
0% positive
Latest IV / EM
565%
EM ±129.3% · $3 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Fri May 8, 2026 | Mar/2026 | $-0.07 | $-0.08 | +12.5% | -16.7% | -5.1% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $0.07 | — | — | — | — | financials |
| Fri Aug 8, 2025 | Jun/2025 | $-0.06 | — | — | — | — | earnings |
| Fri May 9, 2025 | Mar/2025 | $-0.06 | $-0.07 | +14.3% | — | -3.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.08 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.06 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.05 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.08 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.08 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Fri Aug 14, 2026 | Jun/2026 | OTHER | -$0.08 | -$0.06 | -33.3% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | — | $0 | $0 | $42,000 | — | $42,000 | $57,000 |
| Cost of revenue | $0 | — | $0 | $0 | $42,000 | — | $42,000 | $48,000 |
| Gross profit | $0 | — | $0 | $0 | $0 | — | $0 | $9,000 |
| Operating income | $-4M | — | $-3M | $-3M | $-3M | — | $-3M | $-2M |
| Net income | $-4M | — | $-3M | $-3M | $-3M | — | $-3M | $-2M |
| EPS (diluted) | $0.07 | — | $0.07 | $0.06 | $0.06 | — | $0.08 | $0.06 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4M | $7M | $9M | $11M | $13M | $9M | $7M | $9M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $12M | $15M | $17M | $19M | $21M | $9M | $7M | $10M |
| Total assets | $13M | $16M | $17M | $20M | $22M | $9M | $8M | $10M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $2M | $3M | $2M | $2M | $2M | $1M | $1M | $2M |
| Total equity | $11M | $13M | $15M | $17M | $19M | $8M | $6M | $9M |